[HTML][HTML] Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast …
HJ Burstein, G Curigliano, B Thürlimann, WP Weber… - Annals of oncology, 2021 - Elsevier
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
Diagnostic accuracy of de‐escalated surgical procedure in axilla for node‐positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic …
Y Song, Z Xu, M Liang, Z Liu, J Hou, X Chen… - Cancer …, 2022 - Wiley Online Library
Background More initial clinical node‐positive breast cancer patients achieve axillary
pathological complete response (ax‐pCR) after neoadjuvant systemic therapy (NST) …
pathological complete response (ax‐pCR) after neoadjuvant systemic therapy (NST) …
[HTML][HTML] De-escalating axillary surgery in early-stage breast cancer
EH Hersh, TA King - The Breast, 2022 - Elsevier
The role of axillary surgery has evolved over the last three decades from routine axillary
lymph node dissection (ALND) to sentinel lymph node biopsy to omission of axillary surgery …
lymph node dissection (ALND) to sentinel lymph node biopsy to omission of axillary surgery …
[HTML][HTML] Tailored axillary surgery in patients with clinically node-positive breast cancer: pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57 …
Aim We developed tailored axillary surgery (TAS) to reduce the axillary tumor volume in
patients with clinically node-positive breast cancer to the point where radiotherapy can …
patients with clinically node-positive breast cancer to the point where radiotherapy can …
[HTML][HTML] This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients
V Galimberti, SKR Fontana, E Vicini, C Morigi… - The Breast, 2023 - Elsevier
The increased use of neoadjuvant chemotherapy (NACT) has changed the approach to
breast surgery. NACT allows de-escalation of surgery by both increasing breast …
breast surgery. NACT allows de-escalation of surgery by both increasing breast …
[HTML][HTML] Axillary surgery in node-positive breast cancer
N Maggi, R Nussbaumer, L Holzer, WP Weber - The Breast, 2022 - Elsevier
Long-term follow-up data from multicenter phase III non-inferiority trials confirmed the safety
of omission of axillary dissection in selected patients with clinically node-negative, sentinel …
of omission of axillary dissection in selected patients with clinically node-negative, sentinel …
Is nodal clipping beneficial for node-positive breast cancer patients receiving neoadjuvant chemotherapy?
G Montagna, MK Lee, V Sevilimedu, AV Barrio… - Annals of surgical …, 2022 - Springer
Background In cN1 patients rendered cN0 with neoadjuvant chemotherapy, the false-
negative rate of sentinel lymph node biopsy (SLNB) is< 10% when≥ 3 sentinel lymph nodes …
negative rate of sentinel lymph node biopsy (SLNB) is< 10% when≥ 3 sentinel lymph nodes …
Surgical management of the axilla for breast cancer
A Laws, O Kantor, TA King - Hematology/Oncology Clinics, 2023 - hemonc.theclinics.com
Background Historically, axillary clearance with axillary lymph node dissection (ALND) was
important for the regional control of breast cancer. However, with increasing rates of early …
important for the regional control of breast cancer. However, with increasing rates of early …
The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature …
G Ferrarazzo, A Nieri, E Firpo, A Rattaro, A Mignone… - Current …, 2023 - mdpi.com
Background: In clinically node-positive (cN+) breast cancer (BC) patients who become
clinically node-negative (cN0) following neoadjuvant chemotherapy (NACT), sentinel lymph …
clinically node-negative (cN0) following neoadjuvant chemotherapy (NACT), sentinel lymph …
Long-term outcome in patients with nodal-positive breast cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy
SZ Lim, TK Yoo, SB Lee, J Kim, IY Chung… - Breast Cancer Research …, 2024 - Springer
Purpose Sentinel lymph node biopsy (SLNB) has yet to be accepted as the standard staging
procedure in node positive (cN1) breast cancer patients who had clinical complete response …
procedure in node positive (cN1) breast cancer patients who had clinical complete response …